Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials

COVID-19 pandemic demands a swift response to find therapeutic tools that effectively reduce morbidity and mortality. Despite initial fears, evidence from retrospective observational studies supports the inhibition of the renin-angiotensin system as an emerging pathway to delay or moderate angiotens...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothlin, Rodolfo Pedro, Duarte, Mariano, Pelorosso, Facundo Germán, Nicolosi, Liliana, Salgado, M. Victoria, Vetulli, Héctor Miguel, Spitzer, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039444/
https://www.ncbi.nlm.nih.gov/pubmed/33854432
http://dx.doi.org/10.3389/fphar.2021.603736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039444/
https://www.ncbi.nlm.nih.gov/pubmed/33854432
http://dx.doi.org/10.3389/fphar.2021.603736

Ejemplares similares